Wolverine combines BPC-157 5 mg + TB-500 5 mg in one 10 mg vial. People discuss it for recovery; benefits of this exact blend are unproven.
Why people are interested
People call BPC-157 plus TB-500 the Wolverine stack when discussing tendon, joint and workout recovery. A blend name is not a standardized medicine or proof that combining ingredients helps.
What the research supports
The strongest claims about injury repair remain largely preclinical. A small uncontrolled knee-pain series included BPC-157 plus TB4, but did not test this 5 mg + 5 mg product or prove that a combination works better.
Amount source summary
Two individual reports · not a dosing consensus
Whole-blend amounts in separate accounts: 0.5 mg and 1 mg
Tirzepatide acts on GIP and GLP-1 receptors. It has been studied in human medicine products for blood sugar and metabolic effects.
Why people are interested
Tirzepatide is well known because prescription versions are used for type 2 diabetes, chronic weight management, and certain sleep-apnea patients. JD-2TR is a seller code associated with tirzepatide in listed batch reports.
What the research supports
The strongest evidence belongs to manufactured prescription tirzepatide products studied in clinical trials. FDA approval applies to those products and specific indications, not automatically to a research-only JD-2TR vial.
Amount source summary
Selected public accounts · not a dosing consensus
Reported amount + frequency: 2.5 mg — Once weekly
How often: Each amount stays paired with its own reported schedule.
FDA-approved uses belong to named prescription products and indications; they do not transfer to an online research vial. Human, animal, cell, and anecdotal evidence are different. How we check sources →
Keep learning with PeptideWhy.Free, occasional article updates by email.Sign up +
The free email list
Good questions deserve clear answers.
Get occasional plain-English peptide guides and research updates from PeptideWhy. No account needed.